Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30087309HIVENSG00000198626.19protein_codingRYR2NoNo6262Q92736
TVIS30026953HIVENSG00000198626.19protein_codingRYR2NoNo6262Q92736
TVIS30026954HIVENSG00000198626.19protein_codingRYR2NoNo6262Q92736
TVIS30026955HIVENSG00000198626.19protein_codingRYR2NoNo6262Q92736
TVIS20010032HPVENSG00000198626.19protein_codingRYR2NoNo6262Q92736
TVIS20006227HPVENSG00000198626.19protein_codingRYR2NoNo6262Q92736
TVIS20009184HPVENSG00000198626.19protein_codingRYR2NoNo6262Q92736
TVIS20025362HPVENSG00000198626.19protein_codingRYR2NoNo6262Q92736
TVIS20041295HPVENSG00000198626.19protein_codingRYR2NoNo6262Q92736
TVIS20018417HPVENSG00000198626.19protein_codingRYR2NoNo6262Q92736
TCGA Plot Options
Drug Information
GeneRYR2
DrugBank IDDB01195
Drug NameFlecainide
Target IDBE0005295
UniProt IDQ92736
Regulation Typeinhibitor
PubMed IDs25274603
CitationsMehra D, Imtiaz MS, van Helden DF, Knollmann BC, Laver DR: Multiple modes of ryanodine receptor 2 inhibition by flecainide. Mol Pharmacol. 2014 Dec;86(6):696-706. doi: 10.1124/mol.114.094623. Epub 2014 Oct 1.
GroupsApproved; Withdrawn
Direct ClassificationBenzamides
SMILESFC(F)(F)COC1=CC(C(=O)NCC2CCCCN2)=C(OCC(F)(F)F)C=C1
PathwaysFlecainide Action Pathway
PharmGKBPA449646
ChEMBLCHEMBL652